BIOLENO Review: Pricing, COAs, Testing, and What We Found

An independent BIOLENO review covering 20 normalized price rows, 21 BTLabs batch certificates, measured potency against the certificates' own specification, and what the testing does not cover.

---

BIOLENO is now a curated vendor on PeptideBenchmark. Two things made it straightforward to cover: the storefront exposes a completely open catalog API, and nearly every peptide it sells has a batch certificate attached to it on a public page.

The more interesting finding is what those certificates say when you read past the purity line.

The short version

BIOLENO runs a public WooCommerce storefront whose Store API returns price, stock, and dosage without an account. Dosage is published as a “Weight of the peptide” attribute rather than in the product title, which is why the catalog normalizes cleanly once you read the attribute instead of the name.

Catalog surface	Count	How PB treats it
Peptide products normalized to $/mg	20	Promoted to the pricing board, including both NAD+ sizes
Products deferred	0	Every peptide listing produced a clean mg-normalized row
Excluded as out of scope	1	Bacteriostatic water is sold by volume and carries no mg to normalize

Three listings use house codes rather than compound names — BL-RT3, BL-TR2, and BL-H2O. In each case the vendor’s own product URL names the compound (/product/retatrutide/ is titled “BL-RT3”), so PB maps them from the vendor’s own statement rather than inferring from marketing copy.

The certificates

The public COA page links each certificate as a signed storage object. Those signatures carry an explicit expiry, and the current ones run to 2036 — worth stating, because a certificate library whose links quietly expire is a weaker claim than one that stays reachable.

Every certificate in the corpus is issued by BTLabs (5730 Corporate Way, West Palm Beach, Florida) and names BIOLENO as the customer. Reported purity is consistently high: 99.4% to 99.8% across all 21, averaging 99.71%.

BTLabs is a real laboratory and an approved provider name in PeptideBenchmark’s registry. It does not, however, publish a public verification portal — every conventional verify route returns 404. So while each certificate carries a report number and a BT Sample ID, neither can be checked against the laboratory by a reader. These stay classified as named-lab, vendor-hosted documents. That distinction is the difference between “a document exists” and “the issuing lab confirms this document,” and PB does not collapse the two.

Measured potency is the finding

Each BTLabs certificate prints its own acceptance window for potency: 90–110% of the labeled quantity. It then reports the measured result against that window.

Ten of the 21 certificates report a result outside it — every one of them above the ceiling, none below the floor:

Compound	Batch	Measured vs label
Selank	SK10-202604-01	151.4%
NAD+ 1000mg	NJ1000-2020605-01	123.9%
Melanotan II	MT10-202604-01	123.3%
Tesamorelin	TSM10-202604-01	117.3%
Semax	XA10-202604-01	113.7%
MOTS-c	MS10-202605-02	113.5%
Epithalon	ET10-202604-01	113.3%
AOD-9604	10AD0202604-01	112.5%
Sermorelin	SMO10-202604-01	111.6%
MOTS-c	MS10-202604-01	111.1%

Read carefully, this is overfill, not shortfall. A vial containing more than the label states is a different problem from one containing less, and on a value basis it favours the buyer. But it is still a finding, for two reasons.

First, it means the labeled quantity is not a reliable guide to vial contents. A Selank vial labeled 10 mg that assays at 15.1 mg is not a 10 mg vial in any practical sense, and anyone measuring by label is measuring against a number the certificate itself contradicts.

Second, the vendor publishes these certificates as evidence of quality without flagging that a substantial share of them miss the specification printed on the same page. PB records the measured figure alongside the purity figure precisely so that a high purity number does not stand in for the whole result.

What the testing does not cover

The certificate states its own limits in plain text: it “does not provide information on particulate matter, microbial contamination or presence of endotoxins.”

So the panel coverage here is identity, purity, potency, appearance, and recorded mass — and nothing else. No sterility testing. No endotoxin testing. No heavy-metals testing.

This is worth stating explicitly because an early automated read of this corpus reported an endotoxin panel on all 21 documents. It had matched the sentence in which the laboratory excludes endotoxins. A keyword that appears in a disclaimer is not a panel, and PB’s extraction now reads the certificate’s result table rather than its prose.

Pricing

All 20 peptide rows normalize to a per-mg comparison on the pricing board. Headline vial prices run $40 to $90, with the widest range on NAD+ ($60 for 100 mg, $90 for 1000 mg). Free shipping is advertised over $150 and same-day dispatch before 4 PM ET — both vendor-stated, dated to this review, and not independently timed by PB.

One product, Adamax, was out of stock at review. It still carries a published price and dosage, so it is recorded rather than dropped; it is also the one catalog peptide with no certificate on the COA page.

Business identity

The public contact page identifies BIOLENO LLC, 30 N Gould St, Suite 63950, Sheridan, Wyoming 82801, with a (307) 343-7273 support line. That building is a widely used registered-agent address rather than a demonstrated fulfilment site, so PB maps it as the vendor’s published business address and nothing more.

Why BIOLENO is curated

Curated does not mean endorsed. It means PeptideBenchmark has enough evidence and pipeline coverage to maintain a structured, reviewable record. For BIOLENO that includes:

• a public catalog API with live price, stock, and dosage;
• 20 normalized price rows with zero deferrals;
• 21 preserved batch certificates in the COA database;
• extracted purity, measured potency, batch identifier, and panel coverage per certificate;
• an explicit record that these are named-lab rather than provider-verified documents; and
• regression checks that fail if the certificate surface collapses.

The live BIOLENO profile carries the current score and trust band.

Bottom line

BIOLENO’s certificate breadth is genuinely good — 18 of 19 peptides with a real batch document from a named laboratory, openly linked, no account required. Its weaknesses are that nothing in the corpus can be independently verified at the issuing lab, the panels stop well short of sterility or endotoxin, and almost half the batches assay outside the specification their own certificate prints.

That combination is worth knowing in full rather than compressing into a purity headline.

Common questions

Is BIOLENO legitimate?

PeptideBenchmark does not issue binary legitimacy or product-safety endorsements. BIOLENO publishes an open catalog API, an identified Wyoming business contact surface, and a batch certificate for nearly every peptide it sells. That supports an inspectable vendor record; it does not independently establish the identity, condition, or safety of a physical vial.

Does BIOLENO publish COAs?

Yes. On July 31, 2026, its public COA page linked 21 batch certificates covering 18 of the 19 peptides in its catalog. Every certificate is issued by BTLabs of West Palm Beach, Florida, and names BIOLENO as the customer. No account is required to open them.

Are BIOLENO COAs independently verifiable?

Not currently. BTLabs is a real, named laboratory, but it publishes no public verification portal — every conventional verify route returns 404. The certificates carry a report number and a BT Sample ID, but a reader cannot confirm either against the laboratory, so PeptideBenchmark records these as named-lab vendor-hosted documents rather than provider-verified reports.

What do BIOLENO's certificates actually test?

HPLC purity, HPLC potency, FTIR identity, appearance, and recorded mass. The certificate states in its own text that it does not provide information on particulate matter, microbial contamination, or endotoxins. There is no sterility, endotoxin, or heavy-metals testing in this corpus.

Does PeptideBenchmark have an affiliate relationship with BIOLENO?

No. At the time of this review, PeptideBenchmark had no affiliate, coupon, sponsorship, or paid-placement relationship with BIOLENO.